These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16244854)

  • 1. Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers.
    Waterer GW
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):691-2. PubMed ID: 16244854
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pneumococcal pneumonia: what's in an MIC?
    Crnich CJ; Proctor RA
    Crit Care Med; 2004 Mar; 32(3):876-8. PubMed ID: 15090976
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
    Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
    Jacobs MR
    Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microbiological diagnosis of community-acquired pneumopathies].
    Péan Y
    Med Mal Infect; 2011 Jan; 41(1 Suppl 1):H2-4. PubMed ID: 21335251
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe pneumonia and a second antibiotic.
    Macfarlane J
    Lancet; 2002 Apr; 359(9313):1170-2. PubMed ID: 11955532
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
    Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in the treatment of pneumococcal community-acquired pneumonia.
    Feldman C; Anderson R
    Future Microbiol; 2006 Oct; 1(3):271-81. PubMed ID: 17661640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
    Shorr AF; Kollef M; Eckburg PB; Llorens L; Friedland HD
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):298-303. PubMed ID: 23357290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
    Plouffe JF; Martin DR
    Infect Dis Clin North Am; 2004 Dec; 18(4):963-74; x-xi. PubMed ID: 15555834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome.
    Blanc V; Mothes A; Smetz A; Timontin I; Guardia MD; Billiemaz A; Dellamonica J; Vassallo M; Néri D; Chadapaud S; Toyer AL; Del Guidice P; Fribourg A; Léotard S; Nicolle I; Roger PM
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2455-61. PubMed ID: 26476549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
    Moroney JF; Fiore AE; Harrison LH; Patterson JE; Farley MM; Jorgensen JH; Phelan M; Facklam RR; Cetron MS; Breiman RF; Kolczak M; Schuchat A
    Clin Infect Dis; 2001 Sep; 33(6):797-805. PubMed ID: 11512085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe pneumococcal pneumonia: new strategies for management.
    Chiou CC; Yu VL
    Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
    Mufson MA; Stanek RJ
    Clin Infect Dis; 2006 Jan; 42(2):304-6. PubMed ID: 16355349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.